Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.

Abstract

OBJECTIVES:

The expression of syndecan-1, a cell surface heparan sulfate proteoglycan, is reduced during malignant transformation of squamous cells. Studies on squamous cell carcinoma of the head and neck have shown that syndecan-1-positive tumors are associated with longer overall and recurrence-free survival. The purpose of this study was to analyze syndecan-1 expression in invasive cervical carcinoma and to examine the association of syndecan-1 expression with prognostic factors and overall survival.

METHODS:

The study population consisted of 124 patients treated for primary invasive carcinoma of the uterine cervix at the Turku University Central Hospital during the years 1970-1988. The material consisted of 102 (82.3%) squamous cell carcinomas, 16 (12.9%) adenocarcinomas and 1 (0.8%) adenosquamous carcinoma, 1 (0.8%) small cell carcinoma, 1 (0. 8%) adenoid basal carcinoma, 1 (0.8%) carcinosarcoma, and 2 (1.6%) unclassified cervical carcinomas. Syndecan-1 expression was determined on paraffin-embedded tissue blocks using a human syndecan-1-specific monoclonal antibody B-B4 and immunohistochemistry. The expression of syndecan-1 was classified according to staining intensity as well as the percentage of positively stained tumor cells.

RESULTS:

Staining intensity was strong in 44 (36%) samples, while 24 (19%) specimens remained syndecan-1-negative. In 49 (40%) samples, the percentage of syndecan-1-positive cells was >/=90%. Syndecan-1 expression, as determined by >/=50% positively stained tumor cells, was associated with the grade of differentiation (P = 0.03) and squamous histology (P < 0.001), but was not associated with clinical stage (P = 0.16) or disease-free survival (P = 0.86). Age (P = 0.003) and clinical stage (P < 0.001) were significant prognostic factors, but syndecan-1 expression determined neither by percentage of positively stained tumor cells nor by staining intensity was associated with the outcome.

CONCLUSIONS:

In cervical carcinoma syndecan-1 is associated with histological differentiation grade and squamous histology, but does not predict clinical outcome.

• Authors: M Rintala, P Inki, P Klemi, M Jalkanen, S Grénman
• Journal: Gynecologic oncology (Gynecol Oncol) Vol. 75 Issue 3 Pg. 372-8 (Dec 1999) ISSN: 0090-8258 [Print] United States
• PMID: 10600292 (Publication Type: Journal Article)
• Copyright: Copyright 1999 Academic Press.

Chemical References

• Membrane Glycoproteins
• Proteoglycans
• SDC1 protein, human
• Syndecan-1
• Syndecans

Topics

• Adult
• Aged
• Aged, 80 and over
• Carcinoma, Squamous Cell (chemistry, pathology)
• Female
• Humans
• Immunohistochemistry
• Membrane Glycoproteins (analysis)
• Middle Aged
• Neoplasm Staging
• Prognosis
• Proteoglycans (analysis)
• Syndecan-1
• Syndecans
• Uterine Cervical Neoplasms (chemistry, mortality, pathology)